Business

Rett Syndrome NDA accepted for Priority Review by FDA

Rett Syndrome NDA accepted for Priority Review by FDA

articleNeuren Pharmaceuticals LimitedSeptember 12, 20224/company/neuren-pharmaceuticals-ltd/news/rett-syndrome-nda-accepted-for-priority-review-by-fda
Rett Syndrome NDA accepted for Priority Review by FDA

About this update from Neuren Pharmaceuticals Limited

[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":250,"tagName":"div"}]

More updates from Neuren Pharmaceuticals Limited